PRF Technologies Ltd.
corporate_fare Company Profile
PRF Technologies Ltd. (NASDAQ:PRFX) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 36 items for PRFX at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- PRF-110 Preclinical Study Shows 72-Hour Pain Relief Comparable to Approved Benchmark
- PRF Technologies Finalizes Highly Dilutive $10M Equity Line with YA II PN, LTD., Registering 345% of Outstanding Shares for Resale
- PRF Technologies Files for Resale of Shares Under Highly Dilutive $10M Equity Line
- PRF Technologies Secures $10M Equity Line of Credit, Paving Way for Significant Dilution
- FDA Clears PRF Technologies' OcuRing™-K for Phase II Trial in Post-Cataract Pain, Advancing Key Drug Candidate
Financial Snapshot
Insider Transactions
PRFX files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.